Valneva and Dynavax Collaborate to Develop COVID-19 Vaccine Post author:Sam Post published:April 23, 2020 Post category:Devices & Diagnostics Letter Dynavax used the adjuvant in its FDA-approved hepatitis B vaccine. Source: Devices & Diagnostics Letter You Might Also Like FDA Grants Priority Review for Liso-Cel in B-cell Lymphoma February 24, 2020 J&J Partners With Emergent to Produce COVID-19 Vaccine April 23, 2020 CDRH Extends Response Dates for Marketing Applications March 24, 2020
